Sanbo Hospital Management Group Limited (SHE:301293)
China
· Delayed Price · Currency is CNY 63.88
+0.67 (1.06%)
At close: Apr 29, 2026
SHE:301293 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 1,725 | 1,419 | 1,305 | 1,064 | 1,132 | Upgrade
|
| Other Revenue | - | 10.6 | 8.39 | 5.97 | 4.82 | Upgrade
|
| Revenue | 1,725 | 1,429 | 1,313 | 1,070 | 1,137 | Upgrade
|
| Revenue Growth (YoY) | 20.69% | 8.84% | 22.73% | -5.90% | 15.20% | Upgrade
|
| Cost of Revenue | 1,323 | 1,096 | 1,020 | 838.33 | 863.59 | Upgrade
|
| Gross Profit | 402.27 | 333.27 | 293.18 | 231.76 | 273.63 | Upgrade
|
| Selling, General & Admin | 248.54 | 191.94 | 162.4 | 140.89 | 151.79 | Upgrade
|
| Other Operating Expenses | 4.5 | 1.34 | 0.6 | 0.1 | -0.02 | Upgrade
|
| Operating Expenses | 253.04 | 193.51 | 164.38 | 140.01 | 152.32 | Upgrade
|
| Operating Income | 149.24 | 139.76 | 128.8 | 91.75 | 121.3 | Upgrade
|
| Interest Expense | - | -7.85 | -9.69 | -11.69 | -11.56 | Upgrade
|
| Interest & Investment Income | 0.98 | 11.48 | 15.71 | 7.19 | 3.71 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.27 | -1.15 | -1.04 | -1.85 | -2.99 | Upgrade
|
| EBT Excluding Unusual Items | 123.95 | 142.24 | 133.78 | 85.4 | 110.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.82 | 9.06 | 5.34 | 4.12 | 7.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | 0.05 | 0.05 | 0.22 | 0.1 | Upgrade
|
| Asset Writedown | -5.09 | -1.22 | -0.44 | -0.26 | -0.59 | Upgrade
|
| Legal Settlements | - | - | - | - | -4.64 | Upgrade
|
| Other Unusual Items | - | 1.26 | -20.43 | 9.82 | 1.43 | Upgrade
|
| Pretax Income | 119.64 | 151.39 | 118.3 | 99.29 | 114.18 | Upgrade
|
| Income Tax Expense | 47.31 | 35.81 | 33.77 | 21.92 | 26.8 | Upgrade
|
| Earnings From Continuing Operations | 72.33 | 115.58 | 84.53 | 77.37 | 87.38 | Upgrade
|
| Minority Interest in Earnings | 11.86 | -10.55 | -6.29 | -13.92 | -10.68 | Upgrade
|
| Net Income | 84.18 | 105.03 | 78.24 | 63.45 | 76.69 | Upgrade
|
| Net Income to Common | 84.18 | 105.03 | 78.24 | 63.45 | 76.69 | Upgrade
|
| Net Income Growth | -19.85% | 34.24% | 23.31% | -17.27% | 24.22% | Upgrade
|
| Shares Outstanding (Basic) | 205 | 206 | 191 | 156 | 154 | Upgrade
|
| Shares Outstanding (Diluted) | 205 | 206 | 191 | 156 | 154 | Upgrade
|
| Shares Change (YoY) | -0.30% | 7.92% | 22.62% | 0.73% | 2.59% | Upgrade
|
| EPS (Basic) | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 | Upgrade
|
| EPS (Diluted) | 0.41 | 0.51 | 0.41 | 0.41 | 0.50 | Upgrade
|
| EPS Growth | -19.61% | 24.39% | 0.56% | -17.87% | 21.77% | Upgrade
|
| Free Cash Flow | -398.17 | -379.88 | 76 | 62.95 | -23.07 | Upgrade
|
| Free Cash Flow Per Share | -1.94 | -1.84 | 0.40 | 0.41 | -0.15 | Upgrade
|
| Dividend Per Share | - | 0.148 | 0.073 | - | - | Upgrade
|
| Dividend Growth | - | 102.46% | - | - | - | Upgrade
|
| Gross Margin | 23.32% | 23.32% | 22.32% | 21.66% | 24.06% | Upgrade
|
| Operating Margin | 8.65% | 9.78% | 9.81% | 8.57% | 10.67% | Upgrade
|
| Profit Margin | 4.88% | 7.35% | 5.96% | 5.93% | 6.74% | Upgrade
|
| Free Cash Flow Margin | -23.08% | -26.58% | 5.79% | 5.88% | -2.03% | Upgrade
|
| EBITDA | 232.43 | 182.72 | 172.05 | 139.87 | 165.24 | Upgrade
|
| EBITDA Margin | 13.47% | 12.78% | 13.10% | 13.07% | 14.53% | Upgrade
|
| D&A For EBITDA | 83.19 | 42.97 | 43.25 | 48.13 | 43.94 | Upgrade
|
| EBIT | 149.24 | 139.76 | 128.8 | 91.75 | 121.3 | Upgrade
|
| EBIT Margin | 8.65% | 9.78% | 9.81% | 8.57% | 10.67% | Upgrade
|
| Effective Tax Rate | 39.55% | 23.65% | 28.55% | 22.07% | 23.47% | Upgrade
|
| Revenue as Reported | - | 1,429 | 1,313 | 1,070 | 1,137 | Upgrade
|
| Advertising Expenses | - | 12.16 | 3.25 | 0.89 | 0.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.